Committed to promoting healthy outcomes

About Us

Quadrant Biosciences Inc. is a collaborative effort led by company founder Richard Uhlig. Our management team has been carefully balanced to facilitate the ongoing development, testing and distribution of our products, and includes expertise in engineering, FDA regulatory compliance, production, marketing and sales. Our advisory board comprises highly regarded medical experts and data scientists.

Executive Team

Richard Uhlig

Founder and Chief Executive Officer

With more than 25 years of business experience focused on the design and development of innovative products across various industries, Richard’s management capabilities range from ownership of regional retail businesses to the start-up and management of major corporate divisions with domestic and international product sourcing and sales experience. Previously, he was the Chairman and Chief Executive Officer of Morgan Stanley Bank, the principal banking subsidiary of Morgan Stanley, and was the Chief Investment Officer at Merrill Lynch Bank. He held other significant posts in the financial industry and served as an Executive in Residence at Cornell University’s Johnson Graduate School of Management. Richard is a graduate of Cornell University.

David MacLean

Chief Marketing Officer

David has more than 25 years of business, research and legal experience. He recently produced two award-winning feature and documentary films and founded an MMA website and clothing company. David was the co-owner of a mixed-martial arts promotion company and co-owner and manager of a medical-device sales distribution company. Previously, he was a litigator at the firms of LeBoeuf, Lamb, Lieby & MacRae, and Nixon Hargrave Devans & Doyle. Earlier, he was a research biologist for the Cornell University Lab of Ornithology. David earned a BS from Cornell University and a JD from the University of Buffalo Law School, where he was a member of the Law Review.

James Croke

General Counsel

Jim was previously a structured finance/banking partner at Chapman & Cutler, Orrick, Herrington, Cadwalader and Hunton & Williams. Throughout his career, he served as counsel to underwriters and issuers in U.S. and global public offerings and private placements. Jim has been a member of the board of directors of the American Securitization Forum and a faculty member of the Practicing Law Institute. He has written and lectured on a variety of topics regarding legal and regulatory issues and annually served as a guest lecturer regarding U.S. corporate and finance law at The Universidad Panamericana in Guadalajara, Mexico. Jim practiced U.S. law in London from 1999 - 2004, as the head of Cadwalader, Wickersham & Taft LLP's London capital markets department. Jim earned his undergraduate degree in Mathematics from the University of Kentucky and his J.D. degree from the University of Notre Dame Law School.

Richard Bongo

Chief Financial Officer

Mr. Bongo has over 30 years of finance experience while working at many major Wall Street firms. He is most recently was a Managing Director at BNP Paribas, one of Europe's largest banks, and has also worked at such firms as Lehman Brothers, Credit Suisse, Merrill Lynch and Bank of America. Mr. Bongo's experience spans several different disciplines in structured finance including structuring, trading and sales at the institutional level, where he helped to usher in several cutting edge financial investment products such as Collateralized Mortgage Obligations and Commercial Mortgage Backed Securities and Collateralized Loan Obligations. Mr. Bongo began his career at Coopers & Lybrand (Pricewaterhouse Coopers) where he received his CPA. He holds degrees in both Computer Information Systems and Accounting from Kings College.

Benjamin Perry

Chief Technology Officer

Ben’s career in technology encompasses a wide breadth of expertise in software development, including enterprise web applications, cloud computing and human computer interaction. During his experience as both a senior developer and project manager, he led projects involving crowdsourced metadata curation, inventory control tools, and identity management solutions. Before coming to Quadrant Biosciences, Ben developed software for the federal statistical system and public opinion domain. He received his Master’s degree in Information Science from Cornell University.

Bryan Greene

Chief Operating Officer

Bryan brings to the Motion Intelligence team more than 10 years of experience in medical device operations, manufacturing, validation and new-product introduction at both large multinational and start-up corporations. He has a proven track record of successfully introducing Class I, II and III products at Life Technologies (Thermo Fisher Scientific), Pall Corporation and ImClone System (Eli Lilly). Most recently, Bryan was the manufacturing and operations leader during establishment and implementation of an FDA 21CFR820 compliant system at Rheonix, a medical device start-up. He received a BS in Chemical Engineering from Clarkson University.

Randall L. Carpenter, MD

Executive Vice President - Clinical Development

Dr. Carpenter has over 30 years experience in primary care, academic medicine, basic science and clinical research, and pharmaceutical drug development. His experience in the pharmaceutical and biotechnology industries include Co-Founder, President and CEO of Seaside Therapeutics, President and CEO of Sention, VP of Clinical Research & Development and Regulatory Affairs at Adolor Corporation and member of Astra Pain Control’s Global Therapeutic Area Team. While in industry, Dr. Carpenter led translational medicine teams responsible for 8 successful IND submissions and dozens of GCP-compliant clinical trials. Prior to joining industry, he held academic faculty appointments at Virginia Mason Medical Center, the University of Washington and Wake Forest University where he specialized in anesthesiology, pain management and translational medicine.

Chris Horacek

Deputy General Counsel

Chris has more than 20 years of experience as corporate counsel on matters including transactions, business development, intellectual property, and regulatory compliance. He served as Deputy General Counsel and Compliance Officer for Welch Allyn, Inc. for more than 10 years, and in that capacity managed the attorneys in the legal department who worked in the areas of transactions, intellectual property, and compliance, and also served on the executive team that managed the Quality and Regulatory departments. Chris is an adjunct professor at the Syracuse College Of Law, and teaches a section of the class on technology commercialization. He received a BS in Medicine from the University of Nebraska, and a JD, with distinction, from the University of Nebraska College Of Law.

Alexander Rajan, PhD

Vice President - Research

Dr. Rajan has a varied career in biomedical sciences, from basic and translational research, life science and computational biology education and outreach, emergency medicine, and biotech startups. He began his research career investigating autism diagnostics, and has managed, led, and consulted on research projects in vision, somatosensation, proprioception, and motor systems involving biomechanics, neuroanatomy, electrophysiology, and stimulation. His funding sources have included the NSF, NIH, and DARPA. His startup work has been in sales and marketing and in research and development. Dr. Rajan earned a BS in biopsychology from the University of California, Davis and a PhD in computational neuroscience from the University of Chicago.

Andrew Brindle

Vice President - Engineering

Andrew brings a strong background in hardware design and development to the Motion Intelligence team. His career has included over 12 years in the defense industry working on sophisticated radar systems such as the DARPA FORESTER, the Army’s AN/TPQ-49, and radar antennas for drone helicopters. Andrew developed and holds patents on new technologies involving efficient heat transfer, and has a strong background in algorithm development having created algorithms for deep-sea underwater sensors and sports performance technologies. More recently, he has run his own engineering consulting business with a focus on commercial manufacturing and medical devices. Andrew received a B.S. in Mechanical Engineering with a minor in Mathematics from Clarkson University.

Wade West

Executive Vice President - Sales

Mr. West brings over 39 years of entrepreneurial business experience in leadership, sales, marketing and business development. He is the founder and President of General Orthopedics, an orthopedic and neurosurgery focused medical sales and distribution company based in San Antonio, Texas. Mr. West began his career with Minolta Reprographic Systems, eventually becoming a national accounts executive. He then transitioned into the orthopedic market, taking a sales position with Biomet where he was recognized as the top sales representative for four consecutive years. In 1992, Mr. West became the first Biomet Spine distributor in the United States, at which time he founded General Orthopedics. A driven entrepreneur, Wade has provided consulting services to a number of startup and growing companies in the orthopedic and medical device industry. He is actively involved in several charitable organizations including Wish For Our Heroes.

Kayla Wagner

Vice President - Product Management

Kayla has spent her career dedicated to working with children and adolescents with neurodevelopmental disorders in both clinical and research settings. In her clinical work she provided diagnostic and counseling services to children and adolescents with psychiatric disorders. Her research spans many areas of child psychopathology, including autism spectrum disorder, ADHD and 22q11.2 Deletion Syndrome. More specifically, she has investigated the comorbidity between autism and ADHD, genetic and familial relationships within RDOC constructs, and factors related to poor social outcomes (e.g., relationship development/maintenance with friends, family, romantic partners) in children, adolescents, and adults with neurodevelopmental disorders. Kayla earned a BS in neuroscience and psychology and an MS in Clinical Psychology at Syracuse University.

Jeremy Williams

Vice President - Technology

Jeremy has developed software solutions in the financial sector, the GIS industry and in support of large-scale social science research. He has held leadership roles in a number of successful projects, both academically and commercially. He was responsible for designing a citizen science project funded by the NEH and used in secondary schools and colleges across the country. He has also led the development of restricted access Census Bureau metadata repository software funded by the NSF. His experience spans complex systems integration, mapping software used by state and municipal governments to manage geo-spatial data, and applications for research data analysis and dissemination. During Jeremy’s career, he has developed expertise in a variety of technologies, with a focus on information system architecture. He graduated with a Master’s degree in Information Science from Cornell University.

Margaret Barry

Vice President - Treasurer

Margaret brings over 20 years of finance and accounting experience from various industries ranging from start-ups to a Fortune 500 Company. Margaret has been recognized for her ability to analyze large data sets from subsidiaries in Hong Kong, China and Vietnam and guide key decision making based on her analysis. She collaborated and led key aspects during the due diligence of a private equity investment in the company. Margaret received her Bachelor of Science in Electrical Engineering at Cornell University and graduated summa cum laude with her MBA from Emory University.

Scott Giambalvo

Executive Vice President - Functional Assessment Systems

Scott has over 25 years experience in the medical device and health industry working with both multi-national corporations and startup companies. For the last ten years, he has managed Scott Alan Enterprises, a boutique firm building management organizations, creating driven sales teams, and implementing strategic positioning and marketing campaigns to fill needed skill sets for medical device and health IT companies. Previously, Scott honed his leadership skills and industry knowledge for fourteen years at Stryker Corporation and later at OraMetrix. Scott earned an MBA in Entrepreneurship & Marketing from Carnegie Mellon University and bachelor's degrees in Economics and Chemistry from Cornell University.

Patrick Bailey

Vice President - Sales

Patrick has over 10 years experience in the medical device and laboratory diagnostic sectors, with in-depth experience in developing operation and sales strategies for startup companies. Patrick also has broad experience successfully leading growth oriented sales organizations, inclusive of sales management, sales representatives, sales training and business development. Prior to joining Quadrant Biosciences, Patrick held sales leadership and consultant positions in the molecular diagnostic field. In addition, Patrick has successfully built multiple laboratory diagnostic sales teams in neurology, cardiology, pediatrics, family medicine, pathology and internal medicine medical specialities. Patrick is a graduate of Trinity University and holds a Masters of Science degree from California University.

Naved Ameen

Executive Vice President - Corporate Strategy

Naved Ameen has over 25 years experience working in a variety of financial roles. He began his career in investment banking at Smith Barney, advising institutions ranging from credit card issuers and state housing authorities to the RTC. A majority of his career was involved with creating, marketing and trading innovative financial products for investors of every type both domestically and internationally. He also has experience as an investor as a fixed income portfolio manager at Dillon Read and as founder and portfolio manager of Tevere Capital, a hedge fund catering to insurance companies. Naved has lead trading desks at Bank of America, Lehman Brothers and Morgan Stanley. He holds a Bachelors in Economics from The University of Pennsylvania.

Medical and Scientific Collaborators

Evdokia Anagnostou, MD

Dr. Evdokia Anagnostou, MD, is a child neurologist and senior clinician scientist at Holland Bloorview Kids Rehabilitation Hospital; associate professor in the department of pediatrics at the University of Toronto; Assistant Director of Holland Bloorview’s Research Institute and co-lead of the Autism Research Centre (ARC). She holds a Canada Research Chair in translational therapeutics in Autism Spectrum Disorder (ASD) and the Dr. Stuart D. Sims Chair in Autism at Holland Bloorview. Dr. Anagnostou’s research focuses on translating genomic and systems biology findings into novel treatments for ASD.

Randall L. Carpenter, MD

Dr. Carpenter has over 30 years experience in primary care, academic medicine, basic science and clinical research, and pharmaceutical drug development. His experience in the pharmaceutical and biotechnology industries include Co-Founder, President and CEO of Seaside Therapeutics, President and CEO of Sention, VP of Clinical Research & Development and Regulatory Affairs at Adolor Corporation and member of Astra Pain Control’s Global Therapeutic Area Team. While in industry, Dr. Carpenter led translational medicine teams responsible for 8 successful IND submissions and dozens of GCP-compliant clinical trials. Prior to joining industry, he held academic faculty appointments at Virginia Mason Medical Center, the University of Washington and Wake Forest University where he specialized in anesthesiology, pain management and translational medicine.

Diana L. Robins, PHD

Diana L. Robins, Ph.D. (University of Connecticut, 2002) is a professor and the Interim Director of the AJ Drexel Autism Institute at Drexel University, where she leads the Research Program in Early Detection and Intervention for ASD. She also holds secondary appointments in Community Health and Prevention and Psychology. Much of her work has centered around developing, validating, and refining a widely-used screening tool for ASD, the Modified Checklist for Autism in Toddlers, or M-CHAT. She is funded by the National Institutes of Health. Dr. Robins serves as the treasurer for the International Society for Autism Research.

David Beversdorf, MD

Dr. Beversdorf graduated from Indiana University and completed Neurology residency at Dartmouth. After his fellowship in Behavioral Neurology at University of Florida, he joined the Ohio State University faculty. He has published on memory disorders, autism, cognitive neuroscience, fMRI, neurpsychopharmacology and drug addiction. He joined the University of Missouri (Radiology, Neurology, Psychology and the Thompson Center) to focus on autism, with particular interest in pharmacofMRI as a potential treatment marker, and gene/stress interactions in autism. Dr. Beversdorf’s work has been published in journals such as Neurology, Journal of Neurology Neuroscience and Psychiatry, Proceedings of the National Academy of Sciences of the United State of America and Lancet. He is also actively involved in the Brain Imaging Center at the University of Missouri. His research has been funded by National Institute of Neurological Diseases and Stroke, National Institute On Drug Abuse, Department of Defense, Autism Treatment Network, the Stallone Fund and the National Alliance for Autism Research. He has joined the University of Missouri in the departments of Radiology, Neurology, Psychology and the Thompson Center as the William and Nancy Thompson Endowed Chair in Radiology to focus on the field of autism, with particular interest in pharmaco-functional neuroimaging as a potential treatment marker, as well as other biomarkers for treatment, and gene/stress interactions in the development of autism.

Kristin Sohl, MD FAAP

Kristin Sohl, MD, FAAP is an Associate Professor of Clinical Child Health at the University of Missouri, Thompson Center for Autism and Neurodevelopmental Disorders and Vice Chair of the Child Health Department. She is a pediatrician with extensive experience in medical diagnosis, evaluation and treatment of children with a concern of autism and other neurodevelopmental disorders. Dr. Sohl is regarded as an expert in quality and process improvement for comprehensive autism diagnostic and longitudinal services. She is the site principal investigator for the Autism Intervention Research for Physical Health/Autism Treatment Network (AIRP/ATN) and serves in national leadership roles with each of these programs. She is the founder of ECHO Autism, an innovative framework to increase community capacity to care for children with autism and other developmental/behavioral concerns. The ECHO Autism program is viewed as a national model in expanding autism diagnosis and treatment to underserved and rural populations-those currently faced with the longest wait times. The ECHO Autism team has established partnerships with other children’s hospitals and autism centers in more than 15 states and 5 countries. Her research focuses on systems change to improve healthcare and also focuses on understanding underlying medical conditions in individuals with autism. Dr. Sohl is a tireless advocate for children and enjoys engaging other physicians in being a voice for children’s health. She is the President Elect of the American Academy of Pediatrics, Missouri Chapter. She completed medical school and pediatric residency at the University of Missouri.

Daniel L. Coury, MD

Daniel L. Coury, MD is Professor of Pediatrics and Psychiatry in the College of Medicine at The Ohio State University and in the Section of Developmental and Behavioral Pediatrics for Nationwide Children’s Hospital in Columbus, Ohio. He has served on the Sub-board on Developmental-Behavioral Pediatrics of the American Board of Pediatrics, the American Board of Psychiatry and Neurology Steering Committee for Child and Adolescent Psychiatry, and on the Executive Committee of the Council of Pediatric Subspecialties. Dr. Coury is a Past President of the Academic Pediatric Association and Past President of the Society for Developmental and Behavioral Pediatrics (SDBP). In 2000 he was honored for his special contributions to developmental-behavioral pediatrics by SDBP. He has a long history of working with the federal Maternal and Child Health Bureau (MCHB), having been a MCHB Developmental-Behavioral Pediatrics Program Director, a Leadership Education in Neurodevelopmental Disabilities (LEND) Director and Medical Director of a University Center for Excellence in Developmental Disabilities (UCEDD). He has published over 80 peer reviewed articles and participated in over 40 clinical trials of vaccines and treatments for ADHD, anxiety and autism. His current primary focus is in his role as Medical Director for the Autism Speaks Autism Treatment Network (ATN) and the HRSA MCHB funded Autism Intervention Research Network on Physical Health (AIR-P). His current research activities include work on early identification of autism, improving dental care for people with autism, promoting transition of people with autism to adult health care and other services, and improving medical care for people with autism through training of primary care providers.

Steven Hicks, MD, PhD

Dr. Hicks is an Assistant Professor of Academic General Pediatrics at Pennsylvania State College of Medicine in Hershey, PA. He is a physician scientist who studies the influence of genetics and the environment on pediatric diseases involving growth and neurodevelopment. More specifically, Dr. Hicks is interested in how peripheral epigenetic factors such as microRNA may be utilized to predict patient oriented outcomes in pediatric disorders of neurodevelopment (e.g. autism, concussion) and growth (e.g. annorexia nervosa, obesity). His research has been recently published in JAMA Pediatrics and the Journal of Neurotrauma.

Frank Middleton, PhD

Dr. Frank Middleton is an Associate Professor in the Department of Neuroscience & Physiology, Department of Psychiatry & Behavioral Sciences and the Department of Biochemistry & Molecular Biology at SUNY Upstate Medical University. He is the founder and director of the SUNY Molecular Analysis Core facility, which specializes in next-generation sequencing analysis, and has published more than 120 peer-reviewed articles and a dozen book chapters. He is a chief section editor for Behavioral Brain Functions and Frontiers in Genetics.

Anthony Petraglia, MD

Chief Medical Officer, Motion Intelligence LLC

Dr. Petraglia is an attending Neurosurgeon at Rochester Regional Health in Rochester, NY, Dr. Petraglia specializes in all aspects of spine and brain surgery. He has extensive subspecialty experience in sports-related neurological injuries, co-authoring with Dr. Julian Bailes the Handbook of Neurological Sports Injuries, a well-regarded treatise on concussion in sports. Dr. Petraglia is the Executive Director of the Rochester Regional Concussion Center.

Christopher Neville, PT, PhD

Dr. Neville is the associate Professor of Clinical Health Practices at SUNY Upstate Medical University, Dr. Neville has a clinical background as a physical therapist, treating patients with mild traumatic brain injury and various orthopedic conditions before completing his PhD in Health Practice Research with a Biometrics focus. He has more than 50 peer-reviewed journal and conference publications, as well as a history of federal grant funding.

Brian Rieger, PhD

Dr. Rieger is the director of the Concussion Center at SUNY Upstate Medical University and a Clinical Assistant Professor of Rehabilitation Psychology, Dr. Rieger specializes in concussion management and sports-related concussion.

Claudine Ward, MD

Dr. Ward is an assistant Professor of Physical Medicine and Rehabilitation at SUNY Upstate Medical University, Dr. Ward is a clinician who specializes in acquired brain injury, including concussion and management of spasticity.

Data Management Collaborators

William C. Block, PhD

Dr. Block is the director of the Cornell Institute for Social and Economic Research (CISER)—home of the world’s most advanced environments for research with restricted social, economic and health data—Dr. Block has Special Sworn Status for working with restricted federal statistical data. Prior to Cornell, he spent nearly 20 years at the Minnesota Population Center.

Board of Directors

Ira Fedder, MD

Dr. Fedder is a fellowship trained orthopedic spine surgeon practicing at the University of Maryland, St. Joseph Medical Center in Towson, Maryland. Dr Fedder is Board Certified by the ABOS as well as the ABSS and an active member of a number of professional organizations. Dr Fedder has participated in a number of clinical trials, has published widely in both the orthopedic and pharmacology literature, and has been an active lecturer speaking about the current and future use of stem cells and other biologics in orthopedics. Dr Fedder received his Doctor of Pharmacy degree from the U of Maryland School of Pharmacy in 1979. Subsequently, Dr. Fedder completed a fellowship in Clinical Pharmacology at Thomas Jefferson University School of Medicine. After teaching at Northeastern University College of Pharmacy and the Veterans Administration in Boston, Dr. Fedder then returned to the University of Maryland where he graduated from the School of Medicine in 1986. After completing his residency in Orthopedic Surgery at the University of Maryland he completed a fellowship at St Joseph Medical Center in Towson. He has practiced as an orthopedic spine surgeon since 1992.

Andrew Rock

Mr. Rock earned a reputation as a successful serial entrepreneur in the global medical technology industry. He is co-founder of K2M Group, a medical device developer based in Leesburg, Va., which became listed as a publicly traded company on NASDAQ on May 5, 2014. While at K2M, Mr. Rock developed over 17 utility and method patents for the treatment of complex spine pathologies including scoliosis, tumor and trauma, as well as for minimally invasive implants. Before his involvement in K2M, Mr. Rock was a member of the executive management team at American Osteomedix, where he co-developed a minimally invasive approach to access and treat osteoporotic compression fractures and tumors in the thoracic spine. From 1993 to 2003, he was Chairman and CEO of Rock Surgical Associates, Inc., a distributor of Orthopedic and Neurosurgical Products in the Mid-Atlantic region. Currently, Mr. Rock is the founder and managing partner of Neuro Spine Ventures LLC, an 82-member global angel investor group. Mr. Rock is also Co-Founder and Executive Director of DP Enterprises Group Inc., which provides product development and global marketing services for med-tech companies. Mr. Rock also serves on the Board of Directors for several corporations, including Quadrant Biosciences, Inc. which focuses on brain health and epigenetics diagnostics; Minneapolis-based St Teresa Medical Inc., a developer of nanotechnology-based hemostatic and dural sealants; Connecticut based Woven Orthopedics, LLC which specializes in fixation and osteoporotic and osteopenic. He is on the board of advisors for Indianapolis-based Recovery Force, LLC, and a pioneer in wearable technology for the medical, sports and defense industry sectors Mr. Rock graduated from Linsly and West Virginia University.

Mary Ann Tyszko

Ms. Tyszko has over 30 years of experience in program planning, execution, and management. She served as Chief Executive Officer and President of SRCTec Inc. from its inception until August 2010. Prior to that, she served as an Executive Vice President, Operations for SRC, responsible for the day-to-day management and financial results of SRC's four business centers. Ms. Tyszko is Chair of the Greater Syracuse Chamber of Commerce Board of Directors, and a Member of Le Moyne College Management Division Advisory Board. She is a National Director of the Association of Old Crows (AOC) and a Member of the Armed Forces Communications and Electronics Association (AFCEA), the Association of the United States Army (AUSA), the United States Field Artillery Association (USFAA), and the National Association of Corporate Directors (NACD). Ms Tyszko also has been Corporate Chair of Go Red for Women, American Heart Association, as well as a Board Member of Manufacturers Association of Central New York (MACNY). She received her MBA and MS in Computer Science from Syracuse University and a BS in Biology from Le Moyne College.

Richard Uhlig

Mr. Uhlig is the Founder and CEO of Quadrant Biosciences Inc. He has more than 29 years of business experience with a focus on leading start-up and high-growth businesses. Previously, Mr. Uhlig served as the Chairman and Chief Executive Officer of Morgan Stanley Bank, the principal banking subsidiary of Morgan Stanley, where he engineered the growth of the bank from $8 billion to $35 billion in less than two years. Prior to Morgan Stanley, Mr. Uhlig was the Chief Investment Officer for Merrill Lynch Bank USA, building and managing a $65 billion proprietary trading portfolio. Prior to Merrill Lynch, Mr. Uhlig served as a Managing Director at Deutsche Bank AG where he was a bond trader and the Co-Head of the Mortgage-Backed Securities Department for the Americas and Asia. Earlier in his career, Mr. Uhlig was an investment banker at Lehman Brothers and Goldman, Sachs & Co. Mr. Uhlig is a graduate of Cornell University and served as an Executive in Residence at Cornell while lecturing at the Johnson Graduate School of Management.

Peter Cohen

Mr. Cohen is currently Chairman of the Board of Cowen Inc., a well-known diversified financial services firm. From November 1992 to May 1994, Mr. Cohen was Vice Chairman and director of Republic New York Corporation, as well as Chairman of Republic’s subsidiary, Republic New York Securities Corporation. Earlier, he was Chairman of the Board and Chief Executive Officer of Shearson Lehman Brothers from 1983 to 1990. During that time, Mr. Cohen played a prominent role in the RJR Nabisco takeover deal that later became the subject of the book and movie “Barbarians at the Gate.” Over his career, Mr. Cohen has served on a number of corporate, industry and philanthropic boards, including the New York Stock Exchange, The Federal Reserve International Capital Markets Advisory Committee, The Depository Trust Company, The American Express Company, Olivetti SpA, Telecom Italia SpA, and Kroll Inc. He is presently a Trustee of Mount Sinai Medical Center, Vice Chairman and Lead Director of the Board of Directors of Scientific Games Corporation and a director of Safe Auto Insurance. Mr. Cohen received a Bachelor of Science from The Ohio State University in 1968 and his Masters of Business Administration from Columbia University in 1969.

James Croke

Jim was previously a structured finance/banking partner at Chapman & Cutler, Orrick, Herrington, Cadwalader and Hunton & Williams. Throughout his career, he served as counsel to underwriters and issuers in U.S. and global public offerings and private placements. Jim has been a member of the board of directors of the American Securitization Forum and a faculty member of the Practicing Law Institute. He has written and lectured on a variety of topics regarding legal and regulatory issues and annually served as a guest lecturer regarding U.S. corporate and finance law at The Universidad Panamericana in Guadalajara, Mexico. Jim practiced U.S. law in London from 1999 - 2004, as the head of Cadwalader, Wickersham & Taft LLP's London capital markets department. Jim earned his undergraduate degree in Mathematics from the University of Kentucky and his J.D. degree from the University of Notre Dame Law School.

Richard Bongo

Mr. Bongo has over 30 years of finance experience while working at many major Wall Street firms. He is most recently was a Managing Director at BNP Paribas, one of Europe's largest banks, and has also worked at such firms as Lehman Brothers, Credit Suisse, Merrill Lynch and Bank of America. Mr. Bongo's experience spans several different disciplines in structured finance including structuring, trading and sales at the institutional level, where he helped to usher in several cutting edge financial investment products such as Collateralized Mortgage Obligations and Commercial Mortgage Backed Securities and Collateralized Loan Obligations. Mr. Bongo began his career at Coopers & Lybrand (Pricewaterhouse Coopers) where he received his CPA. He holds degrees in both Computer Information Systems and Accounting from Kings College.

Wade West

Mr. West brings over 39 years of entrepreneurial business experience in leadership, sales, marketing and business development. He is the founder and President of General Orthopedics, an orthopedic and neurosurgery focused medical sales and distribution company based in San Antonio, Texas. Mr. West began his career with Minolta Reprographic Systems, eventually becoming a national accounts executive. He then transitioned into the orthopedic market, taking a sales position with Biomet where he was recognized as the top sales representative for four consecutive years. In 1992, Mr. West became the first Biomet Spine distributor in the United States, at which time he founded General Orthopedics. A driven entrepreneur, Wade has provided consulting services to a number of startup and growing companies in the orthopedic and medical device industry. He is actively involved in several charitable organizations including Wish For Our Heroes.

We are located in the Institute for Human Performance at SUNY Upstate Medical University.